159 related articles for article (PubMed ID: 37172941)
1. Pathophysiological Aspects of COVID-19-Associated Vasculopathic Diseases.
Greistorfer T; Jud P
Thromb Haemost; 2023 Oct; 123(10):931-944. PubMed ID: 37172941
[TBL] [Abstract][Full Text] [Related]
2. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
Mondal R; Lahiri D; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Paria SR; Thakurta TG; Singla P; Biswas SC
J Thromb Thrombolysis; 2020 Oct; 50(3):567-579. PubMed ID: 32627126
[TBL] [Abstract][Full Text] [Related]
3. The Ways of the Virus: Interactions of Platelets and Red Blood Cells with SARS-CoV-2, and Their Potential Pathophysiological Significance in COVID-19.
Panteleev MA; Sveshnikova AN; Shakhidzhanov SS; Zamaraev AV; Ataullakhanov FI; Rumyantsev AG
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139118
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of immunothrombosis in COVID-19.
Portier I; Campbell RA; Denorme F
Curr Opin Hematol; 2021 Nov; 28(6):445-453. PubMed ID: 34232139
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 - A vascular disease.
Siddiqi HK; Libby P; Ridker PM
Trends Cardiovasc Med; 2021 Jan; 31(1):1-5. PubMed ID: 33068723
[TBL] [Abstract][Full Text] [Related]
6. Potential mechanisms of cerebrovascular diseases in COVID-19 patients.
Lou M; Yuan D; Liao S; Tong L; Li J
J Neurovirol; 2021 Feb; 27(1):35-51. PubMed ID: 33534131
[TBL] [Abstract][Full Text] [Related]
7. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.
Zhu Y; Chen X; Liu X
Front Immunol; 2022; 13():838011. PubMed ID: 35309344
[TBL] [Abstract][Full Text] [Related]
8. The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19.
Six I; Guillaume N; Jacob V; Mentaverri R; Kamel S; Boullier A; Slama M
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682871
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and immunothrombosis.
Cesta MC; Zippoli M; Marsiglia C; Gavioli EM; Cremonesi G; Khan A; Mantelli F; Allegretti M; Balk R
Eur J Immunol; 2023 Jan; 53(1):e2250010. PubMed ID: 36239164
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Dysfunction in COVID-19: Association Between Endothelial Cell Injury and Lactate.
Yang K; Holt M; Fan M; Lam V; Yang Y; Ha T; Williams DL; Li C; Wang X
Front Immunol; 2022; 13():868679. PubMed ID: 35401579
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.
Bonaventura A; Vecchié A; Dagna L; Martinod K; Dixon DL; Van Tassell BW; Dentali F; Montecucco F; Massberg S; Levi M; Abbate A
Nat Rev Immunol; 2021 May; 21(5):319-329. PubMed ID: 33824483
[TBL] [Abstract][Full Text] [Related]
13. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.
Rossouw TM; Anderson R; Manga P; Feldman C
Front Immunol; 2022; 13():776861. PubMed ID: 35185878
[TBL] [Abstract][Full Text] [Related]
14. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
Maruhashi T; Higashi Y
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
[TBL] [Abstract][Full Text] [Related]
16. Endothelial Dysfunction in Covid-19 Infection.
Otifi HM; Adiga BK
Am J Med Sci; 2022 Apr; 363(4):281-287. PubMed ID: 35093394
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and immunothrombosis: emerging understanding and clinical management.
Shaw RJ; Bradbury C; Abrams ST; Wang G; Toh CH
Br J Haematol; 2021 Aug; 194(3):518-529. PubMed ID: 34114204
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
Mezoh G; Crowther NJ
Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
[TBL] [Abstract][Full Text] [Related]
19. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
Gando S; Wada T
Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
